Difference between revisions of "Editorial Board"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) |
Warner-admin (talk | contribs) m |
||
Line 67: | Line 67: | ||
!colspan="3" align="center" style="color:white; font-size:125%; background-color:#3182bd"|'''Gynecologic Oncology''' | !colspan="3" align="center" style="color:white; font-size:125%; background-color:#3182bd"|'''Gynecologic Oncology''' | ||
|- | |- | ||
− | |rowspan= | + | |rowspan=3 style="background-color:#F0F0F0"|[[File:BrandonSeagle.jpg|thumb|upright=0.4|center]] |
− | |rowspan= | + | |rowspan=3|<big>[[User:Blseagle|Brandon L. Seagle, MD, MS]]<br>Chicago, IL</big> |
|style="background-color:#deebf7"|[[Cervical cancer]] | |style="background-color:#deebf7"|[[Cervical cancer]] | ||
|- | |- |
Revision as of 17:11, 10 January 2018
We are in the process of developing an editorial board of clinical experts, organized primarily by disease focus. Many disease sites now have expert representation, but we are still looking for potential section or page editors. If you are interested, please feel free to contact us with any questions or inquiries, at [email protected].
Editor-in-Chief
Peter C. Yang, MD Boston, MA Twitter: Hem_Onc |
Deputy Editor
Jeremy L. Warner, MD, MS Nashville, TN Twitter: Hemoncwarner |